Cerebral edema is the accumulation of fluid in and resultant swelling of the brain that may be caused by lack of oxygen at high altitudes, trauma, a tumor or exposure to toxic substances.
A Spanish hospital research group has developed a pharmaceutical composition with high stability under extreme environmental conditions typical of a high altitude, for the treatment of cerebral edema in acute mountain sickness.
This pharmaceutical composition is presented in an injectable device preloaded whose form of administration may be intramuscular, intravenous or by subcutaneous injection and can be used therefore as an emergency treatment.
The research group is looking for the following collaboration:
-License agreement: framework of authorizing the interested parties to use the solution.
-Technical cooperation agreement: to collaborate with other research teams, companies or foundations.